Chronic transfusion practice for children with sickle cell anaemia and stroke

British Journal of Haematology

Volumn 145, Issue 4, 2009, Pages 524-528

  Aygun, Banu ^a   McMurray, Marsha A ^b   Schultz, William H ^a   Kwiatkowski, Janet L ^c   Hilliard, Lee ^d   Alvarez, Ofelia ^e   Heeney, Matthew ^f   Kalinyak, Karen ^g   Lee, Margaret T ^h   Miller, Scott ⁱ   Helms, Ronald W ^b,j   Ware, Russell E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b RHO INC   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF MIAMI   (United States)

^f BOSTON CHILDREN S HOSPITAL   (United States)

^g CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ SUNY DOWNSTATE MEDICAL CENTER   (United States)

^j UNIVERSITY OF NORTH CAROLINA   (United States)

more..

Author keywords

Hb S level; Sickle cell anaemia; Stroke; Transfusion

Indexed keywords

HEMOGLOBIN S;

ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; SICKLE CELL ANEMIA; STROKE;

ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CHILD; HEMOGLOBIN, SICKLE; HUMANS; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME; UNITED STATES;

EID: 65349084954     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07630.x     Document Type: Article

References (15)

1. Balkaran, B., Char, G., Morris, J.S., Serjeant, B.E. Serjeant, G.R. (1992) Stroke in a cohort of patients with homozygous sickle cell disease. The Journal of Pediatrics, 120, 360 366.
2. Cohen, A.R., Martin, M.B., Silber, J.H., Kim, H.C., Ohene-Frempong, K. Schwartz, E. (1992) A modified transfusion program for prevention of stroke in sickle cell disease. Blood, 79, 1657 1661.
3. Lusher, J.M., Haghighat, H. Khalifa, S. (1976) A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction. American Journal of Hematology, 1, 265 273.
4. Miller, S.T., Jensen, D. Rao, S.P. (1992) Less intensive long-term transfusion therapy for sickle cell anemia and cerebrovascular accident. The Journal of Pediatrics, 120, 54 57.
5. Ohene-Frempong, K. (1991) Stroke in sickle cell disease: demographic, clinical and therapeutic considerations. Seminars in Hematology, 28, 213 219.
6. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. Gill, F.M., and the Cooperative Study of Sickle Cell Disease 1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288 294. (Pubitemid 28018756)
7. Pegelow, C.H., Adams, R.J., McKie, V., Abboud, M., Berman, B., Miller, S.T., Olivieri, N., Vichinsky, E., Wang, W. Brambilla, D. (1995) Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. The Journal of Pediatrics, 126, 896 899.
8. Powars, D., Wilson, B., Imbus, C., Pegelow, C. Allen, J. (1978) The natural history of stroke in sickle cell disease. American Journal of Medicine, 65, 461 471.
9. Russell, M.O., Goldberg, H., Reis, L., Friedman, S., Slater, R., Reivich, M. Schwartz, E. (1976) Transfusion therapy for cerebrovascular abnormalities in sickle cell disease. The Journal of Pediatrics, 88, 382 387.
10. Russell, M.O., Goldberg, H., Hodson, A., Kim, H.C., Halus, J., Reivich, M. Schwartz, E. (1984) Effect of transfusion therapy on arteriographic abnormalities and on recurrence of stroke in sickle cell disease. Blood, 63, 162 169. (Pubitemid 14224534)
11. Sarnaik, S., Soorya, D., Kim, J., Ravindranath, Y. Lusher, J. (1979) Periodic transfusions for sickle cell anemia and CNS infarction. American Journal of Disease of Children, 133, 1254 1257. (Pubitemid 10205404)
12. Scothorn, D.J., Price, C., Schwartz, D., Terrill, C., Buchanan, G.R., Shurney, W., Sarniak, I., Fallon, R., Chu, J.Y., Pegelow, C.H., Wang, W., Casella, J.F., Resar, L.S., Berman, B., Adamkiewicz, T., Hsu, L.L., Ohene-Frempong, K., Smith-Whitley, K., Mahoney, D., Scott, J.P., Woods, G.M., Watanabe, M. Debaun, M.R. (2002) Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. The Journal of Pediatrics, 140, 348 354. (Pubitemid 34289713)
13. Wang, W.C., Kovnar, E.H., Tonkin, I.L., Mulhern, R.K., Langston, J.W., Day, S.W., Schell, M.J. Wilimas, J.A. (1991) High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. The Journal of Pediatrics, 118, 377 382.
14. Ware, R.E., Zimmerman, S.A., Sylvestre, P.B., Mortier, N.A., Davis, J.S., Treem, W.R. Schultz, W.H. (2004) Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy. The Journal of Pediatrics, 145, 346 52. (Pubitemid 39165683)
15. Wilimas, J., Goff, J.R., Anderson, H.R., Langston, J.W. Thompson, E. (1980) Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. The Journal of Pediatrics, 96, 205 208.